Universal Ibogaine Inc.
IBOGF
$0.065
-$0.005-7.14%
| 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 75.03% | 83.08% | 75.99% | 78.44% | 25.10% |
| Total Depreciation and Amortization | 14.48% | 10.17% | 4.64% | 5.25% | 14.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -84.22% | -94.01% | -86.33% | -92.61% | -17.76% |
| Change in Net Operating Assets | 84.23% | 233.38% | 166.38% | 194.37% | -346.28% |
| Cash from Operations | 74.40% | 88.25% | 80.50% | 75.98% | 25.31% |
| Capital Expenditure | 93.99% | 88.86% | -28.26% | -202.52% | -299.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | 122.52% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -107.36% | -118.37% | -152.69% | 86.38% | 110.01% |
| Total Debt Issued | -109.31% | 65.63% | -- | -67.90% | -70.78% |
| Total Debt Repaid | 20.16% | 76.14% | 80.12% | 82.97% | 40.01% |
| Issuance of Common Stock | 161.35% | -22.67% | -82.05% | -91.14% | -91.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -7.28% | 120.76% | 456.56% | -86.77% | -88.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.04% | 105.72% | 85.26% | -161.35% | -210.72% |
